insulin replacement therapy ( 1.2 u/day ) for 3-4 days normalized serum rigf-i levels ( 0.92 +/- 0.07 u/ml ) and increased rigf-i production by isolated hepatocytes to 67 % the rate of normal cells and igf-bp production to 70 % normal .
C0021665
rigf-i
C0037657
igf